US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class I · High risk Terminated

Chlorhexidine Gluconate 0012 For Manufacturing

Reason Microbial contamination of Non-Sterile Product; detection of the gram-negative bacillus Serratia marcescens in certain API batches

Medichem S.A. NDC 53296-0012-0 D-1534-2020
Class I · High risk Terminated

All Clean Hand Sanitizer

Reason Chemical Contamination: Product contains undeclared methanol.

Itech 361 LLC D-1538-2020
Class I · High risk Terminated

ChlroraPrep One-Step

Reason Non-Sterility: Product is being recalled due to presence of Aspergillus Penicilloides

CareFusion 213, LLC D-1511-2020
Class I · High risk Terminated

ChloraPrep With Tint

Reason Non-Sterility: Product is being recalled due to presence of Aspergillus Penicilloides

CareFusion 213, LLC D-1510-2020
Class I · High risk Terminated

BD ChloraPrep Clear 3 mL Applicators

Reason Non-Sterility: Product is being recalled due to presence of Aspergillus Penicilloides

CareFusion 213, LLC NDC 54365-400-32 D-1509-2020
Class III · Low risk Terminated

Tecfidera

Reason cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.

Biogen MA Inc. NDC 64406-006-02 D-1381-2020
Class III · Low risk Terminated

Nystatin Oral Suspension

Reason Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

VistaPharm, Inc. NDC 66689-008-16 D-1378-2020
Class III · Low risk Terminated

Nystatin Oral Suspension

Reason Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.

VistaPharm, Inc. NDC 66689-037-50 D-1377-2020
Class I · High risk Terminated

Saniderm ADVANCED HAND SANITIZER

Reason Chemical Contamination: Product contains undeclared methanol.

Uvt INC D-1407-2020
Class III · Low risk Terminated

Famotidine Injection

Reason TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

HF Acquisition Co. LLC NDC 63323-739-12 D-1392-2020
Class II · Moderate risk Terminated

Metformin HCl Extended Release Tablets

Reason CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Preferred Pharmaceuticals, Inc. D-1364-2020
Class II · Moderate risk Terminated

Childrens Dimetapp Cold & Cough

Reason Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.

Glaxosmithkline Consumer Healthcare Holdings D-1362-2020
Class II · Moderate risk Terminated

Heparin Sodium 5

Reason Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.

SCA Pharmaceuticals NDC 70004-0650-46 D-1311-2020
Class II · Moderate risk Terminated

Tropical Lip Moisturizer

Reason Superpotent Drug: The beginning portion of the batch appears to be approximately 25% superpotent for active ingredient Meradimate.

Yusef Manufacturing Laboratories, LLC D-1486-2020
Class II · Moderate risk Terminated

Clozapine Tablets USP tablet

Reason Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.

Aurobindo Pharma USA Inc. NDC 65862-846-05 D-1370-2020
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended-Release Tablets

Reason CGMP Deviation: Potential presence of Nitrosodimethylamine (NDMA) Impurity above the established levels.

The Harvard Drug Group NDC 00904-5794-61 D-1360-2020
Class II · Moderate risk Terminated

Koala Hand Sanitizer

Reason Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.

Beaming White Llc D-1359-2020
Class II · Moderate risk Terminated

Koala Hand Sanitizer

Reason Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.

Beaming White Llc D-1358-2020
Class II · Moderate risk Terminated

Koala Hand Sanitizer

Reason Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.

Beaming White Llc D-1357-2020
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended-release Tablets USP

Reason CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Lupin Pharmaceuticals Inc. NDC 68180-336-07 D-1334-2020
Class II · Moderate risk Terminated

Irinotecan HCL Injection

Reason Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.

Hikma Pharmaceuticals USA Inc. NDC 0143-9583-01 D-1309-2020
Class II · Moderate risk Terminated

Irinotecan HCL Injection

Reason Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.

Hikma Pharmaceuticals USA Inc. NDC 0143-9701-01 D-1308-2020
Class III · Low risk Terminated

Nabumetone Tablets

Reason Labeling Not Elsewhere Classified: The statement Pharmacist: Dispense with the accompanying Medication Guide was not included on the carton label.

American Health Packaging D-1372-2020
Class II · Moderate risk Terminated

Aripiprazole Tablets

Reason Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count.

Alembic Pharmaceuticals Limited NDC 62332-097-30 D-1341-2020